CODX vs EXC
Co-Diagnostics, Inc. Common Stock (CODX) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
CODX currently screens at market cap $31.4M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the CODX and EXC stock pages for the full models.
Not investment advice.